Strides Pharma Science Limited

FDA Regulatory Profile

Strides Pharma Science Limited has 1 FDA recall, 13 inspections, 0 510(k) clearances and 1 compliance action on record.

Latest recall
D-1029-2020 · Class III · Feb 17, 2020
Latest inspection
May 20, 2026 · VAI

Newer recall under related name Strides Pharma: Oct 7, 2026, D-0079-2027.

Reviewing Strides Pharma Science Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Strides Pharma Science Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections13Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Strides Pharma
Same company group
140110Oct 7, 2026 (D-0079-2027)
Strides Pharma Private Limited
Same company group
0070—

Recent Recalls

NumberClassProductDate
D-1029-2020Class IIIPotassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle, Rx only…Feb 17, 2020

Recent FDA Inspections

DateSiteProductClassificationFEI
May 20, 2026Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Feb 24, 2023Puducherry, IndiaDrugsVoluntary Action Indicated (VAI)3012448465
Dec 9, 2022Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Mar 5, 2020Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612
Jan 17, 2020Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
May 24, 2019Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Feb 5, 2019Puducherry, IndiaDrugsOfficial Action Indicated (OAI)3012448465
Nov 2, 2018Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612
May 26, 2017Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Feb 19, 2016Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Aug 26, 2014Bangalore, IndiaDrugsVoluntary Action Indicated (VAI)3004554612
Dec 20, 2013Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612
Jul 22, 2011Bangalore, IndiaDrugsNo Action Indicated (NAI)3004554612

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3004554612Bangalore, India11May 20, 2026
FEI 3012448465Puducherry, India2Feb 24, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.